Table 2.
Multivariate logistic regression on factors associated with AKI among patients admitted with COVID-19
| OR | 95% lower limit | 95% upper limit | p value | |
|---|---|---|---|---|
| Age | 1.029 | 1.001 | 1.057 | 0.042 |
| BMI | 1.002 | 0.964 | 1.042 | 0.907 |
| Male | ref. | |||
| Female | 0.705 | 0.373 | 1.330 | 0.280 |
| African American | ref. | |||
| Caucasian | 1.874 | 0.451 | 7.785 | 0.387 |
| Hispanic | 0.897 | 0.305 | 2.635 | 0.843 |
| Other | 1.597 | 0.589 | 4.334 | 0.358 |
| COPD | 0.801 | 0.287 | 2.234 | 0.671 |
| DM | 1.435 | 0.747 | 2.754 | 0.278 |
| HTN | 1.750 | 0.791 | 3.872 | 0.167 |
| HF | 3.851 | 10.121 | 13.231 | 0.032 |
| CAD | 0.543 | 0.215 | 1.373 | 0.197 |
| Baseline eGFR | 0.991 | 0.982 | 1.000 | 0.055 |
| ACEi/ARB use | 0.663 | 0.335 | 1.313 | 0.239 |
OR, odds ratio; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HTN, hypertension; HF, heart failure; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate; ACEi/ARB, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers.